These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19322547)

  • 21. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.
    Gao D; Herman JG; Guo M
    Oncotarget; 2016 Jun; 7(24):37331-37346. PubMed ID: 26967246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epigenetics and genetics in neuro-oncology.
    Nagarajan RP; Costello JF
    Neurotherapeutics; 2009 Jul; 6(3):436-46. PubMed ID: 19560734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.
    Lavon I; Refael M; Zelikovitch B; Shalom E; Siegal T
    Neuro Oncol; 2010 Feb; 12(2):173-80. PubMed ID: 20150384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation.
    Hervouet E; Debien E; Campion L; Charbord J; Menanteau J; Vallette FM; Cartron PF
    Clin Cancer Res; 2009 May; 15(10):3519-29. PubMed ID: 19451595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.
    J Dabrowski M; Wojtas B
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative DNA Methylation Analysis at Single-Nucleotide Resolution by Pyrosequencing®.
    Busato F; Dejeux E; El Abdalaoui H; Gut IG; Tost J
    Methods Mol Biol; 2018; 1708():427-445. PubMed ID: 29224157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.
    Zhang BL; Liu J; Lei Y; Xiong Y; Li H; Lin X; Yao RQ; Gao DS
    Mol Neurobiol; 2016 Sep; 53(7):4352-62. PubMed ID: 26232065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.
    Zhang Z; Tang H; Wang Z; Zhang B; Liu W; Lu H; Xiao L; Liu X; Wang R; Li X; Wu M; Li G
    Mol Cancer; 2011 Sep; 10():124. PubMed ID: 21962230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioma epigenetics: From subclassification to novel treatment options.
    Gusyatiner O; Hegi ME
    Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulated chromatin remodeling in the pathobiology of brain tumors.
    Spyropoulou A; Piperi C; Adamopoulos C; Papavassiliou AG
    Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation in adult diffuse gliomas.
    LeBlanc VG; Marra MA
    Brief Funct Genomics; 2016 Nov; 15(6):491-500. PubMed ID: 27288434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic regulation of DNA repair genes and implications for tumor therapy.
    Christmann M; Kaina B
    Mutat Res Rev Mutat Res; 2019; 780():15-28. PubMed ID: 31395346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas.
    Bello MJ; Rey JA
    Cancer Genet Cytogenet; 2006 Jan; 164(2):172-3. PubMed ID: 16434325
    [No Abstract]   [Full Text] [Related]  

  • 34. Aberrant promoter methylation and expression of the imprinted PEG3 gene in glioma.
    Otsuka S; Maegawa S; Takamura A; Kamitani H; Watanabe T; Oshimura M; Nanba E
    Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(4):157-65. PubMed ID: 19367087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.
    Liang G; Weisenberger DJ
    Epigenetics; 2017 Jun; 12(6):416-432. PubMed ID: 28358281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transglutaminase 2 gene is aberrantly hypermethylated in glioma.
    Dyer LM; Schooler KP; Ai L; Klop C; Qiu J; Robertson KD; Brown KD
    J Neurooncol; 2011 Feb; 101(3):429-40. PubMed ID: 20596752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Smad"eningly erratic: target gene methylation determines whether TGFbeta promotes or suppresses malignant glioma.
    Kesari S; Jackson-Grusby L; Stiles CD
    Dev Cell; 2007 Mar; 12(3):324-5. PubMed ID: 17336898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation level of promoter region of activating transcription factor 5 in glioma.
    Hua XM; Wang J; Qian DM; Song JY; Chen H; Zhu XL; Zhou R; Zhao YD; Zhou XZ; Li L; Zhang L; Song XX; Wang B
    J Zhejiang Univ Sci B; 2015 Sep; 16(9):757-62. PubMed ID: 26365117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation as a diagnostic tool.
    Galbraith K; Snuderl M
    Acta Neuropathol Commun; 2022 May; 10(1):71. PubMed ID: 35527288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
    Mapelli P; Aboagye EO; Stebbing J; Sharma R
    Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.